Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Total article views   Abstract views HTML views PDF downloads Totals
5,773 Dovepress* 4,030 968+ 802 4,998
PubMed Central* 0 775 173 775
Totals 4,030 1,743 975 5,773
*Since 1 June 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 6 8

View citations on PubMed Central and Google Scholar